f SARS-CoV-2 or Vaccinal Spike Protein can Induce Mast Cell Activation Syndrome (MCAS)

References

1. PetraA.I. PanagiotidouS. StewartJ.M. ContiP. TheoharidesT.C. Spectrum of mast cell activation disorders.Expert Rev. Clin. Immunol.201410672973910.1586/1744666X.2014.906302 24784142
   [Google Scholar]
2. MolderingsG.J. BrettnerS. HomannJ. AfrinL.B. Mast cell activation disease: A concise practical guide for diagnostic workup and therapeutic options.J. Hematol. Oncol.2011411010.1186/1756‑8722‑4‑10 21418662
   [Google Scholar]
3. MarshallJ.S. WarringtonR. WatsonW. KimH.L. An introduction to immunology and immunopathology.Allergy Asthma Clin. Immunol.201814S24910.1186/s13223‑018‑0278‑1 30263032
   [Google Scholar]
4. AbrahamS.N. St JohnA.L. Mast cell-orchestrated immunity to pathogens.Nat. Rev. Immunol.201010644045210.1038/nri2782 20498670
   [Google Scholar]
5. MetcalfeD.D. PeavyR.D. GilfillanA.M. Mechanisms of mast cell signaling in anaphylaxis.J. Allergy Clin. Immunol.2009124463964610.1016/j.jaci.2009.08.035 19815110
   [Google Scholar]
6. AkinC. ValentP. MetcalfeD.D. Mast cell activation syndrome: Proposed diagnostic criteria.J. Allergy Clin. Immunol.2010126610991104.e410.1016/j.jaci.2010.08.035 21035176
   [Google Scholar]
7. FrieriM. PatelR. CelestinJ. Mast cell activation syndrome: A review.Curr. Allergy Asthma Rep.2013131273210.1007/s11882‑012‑0322‑z 23179866
   [Google Scholar]
8. AnnweilerC. CaoZ. WuY. Counter-regulatory ‘Renin-Angiotensin’ system-based candidate drugs to treat COVID-19 diseases in SARS-CoV-2-infected patients.Infect. Disord. Drug Targets202020440740810.2174/22123989MTA2cNzIlw 32418532
   [Google Scholar]
9. El-ArifG. FarhatA. KhazaalS. The renin-angiotensin system: A key role in SARS-CoV-2-induced COVID-19.Molecules20212622694510.3390/molecules26226945 34834033
   [Google Scholar]
10. El-ArifG. KhazaalS. FarhatA. Angiotensin II type I receptor (AT1R): The gate towards COVID-19-associated diseases.Molecules2022277204810.3390/molecules27072048 35408447
    [Google Scholar]
11. KhazaalS. HarbJ. RimaM. The pathophysiology of long COVID throughout the renin-angiotensin system.Molecules2022279290310.3390/molecules27092903 35566253
    [Google Scholar]
12. SabatierJ-M. FajlounZ. LegrosC. COVID-19 and ehlers-danlos syndrome: The dangers of the spike protein of SARS-CoV-2.Infect. Disord. Drug Targets2023233e04012321237510.2174/1871526523666230104145108 36600622
    [Google Scholar]
13. FajlounZ. KhattarA.Z. KovacicH. LegrosC. SabatierJ.M. Why do athletes develop very severe or fatal forms of COVID after intense exercise following SARS-CoV-2 infection or anti-COVID vaccination?Infect. Disord. Drug Targets2023234e11012321256310.2174/1871526523666230111104355 36631923
    [Google Scholar]
14. FajlounZ. KhattarA.Z. KovacicH. LegrosC. SabatierJ.M. SIBO: The trail of a “New” human pathology associated with multiple severe and disabling COVID-19 and long COVID symptoms or induced by the anti-COVID-19 vaccine.Infect. Disord. Drug Targets2023234e10022321359310.2174/1871526523666230210162334 36762752
    [Google Scholar]
15. FajlounZ. KhattarA.Z. KovacicH. LegrosC. SabatierJ.M. Anti-COVID-19 vaccination, COVID-19, and female contraception: The exacerbated risks (Thromboembolism) of the estrogen-progestin pill.Infect. Disord. Drug Targets2023234e24022321400010.2174/1871526523666230224094439 36823996
    [Google Scholar]
16. FajlounZ. Abi KhattarZ. KovacicH. LegrosC. SabatierJ.M. Understanding and relieving of neuropathic disorders in the long COVID.Infect. Disord. Drug Targets2023234e27022321406110.2174/1871526523666230227113205 36843369
    [Google Scholar]
17. FajlounZ. KhattarA.Z. KovacicH. SabatierJ.M. COVID-19 and anti-COVID-19 vaccination: Potential damages to the thyroid gland.Infect. Disord. Drug Targets2023236e09052321669810.2174/1871526523666230509112038 37165584
    [Google Scholar]
18. FajlounZ. WuY. CaoZ. KovacicH. SabatierJ.M. COVID-19 and Alzheimer’s Disease: The link finally established.Infect. Disord. Drug Targets2023237e29052321742810.2174/1871526523666230529162633 37254552
    [Google Scholar]
19. FajlounZ. WuY. CaoZ. KovacicH. SabatierJ.M. COVID-19 and Parkinson’s Disease: The link also established!Infect. Disord. Drug Targets2023238e19062321806110.2174/1871526523666230619104142 37340743
    [Google Scholar]
20. FajlounZ. Abi KhattarZ. SabatierJ.M. The intriguing connection between cholestasis and the renin-angiotensin system dysregulation induced by SARS-CoV-2 and/or the vaccinal spike protein.Infect. Disord. Drug Targets202424Advance online publication10.2174/0118715265304515240220105152 38465438
    [Google Scholar]
21. FajlounZ. SabatierJ.M. The unsuspected role of the renin-angiotensin system (RAS): Could its dysregulation be at the root of all non-genetic human diseases?Infect. Disord. Drug Targets2023241e14092322108510.2174/1871526524666230914114524 37711109
    [Google Scholar]